Hepatitis B and C in children: Current treatment and future strategies

Clinics in Liver Disease

Volumn 10, Issue 1, 2006, Pages 133-148

  Elisofon, Scott A ^a,b   Jonas, Maureen M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; CLEVUDINE; EMTRICITABINE; ENTECAVIR; ERYTHROPOIETIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; TELBIVUDINE;

ANEMIA; ANOREXIA; ARTHRALGIA; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG FEVER; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; GENOTYPE PHENOTYPE CORRELATION; HEADACHE; HEPATITIS B; HEPATITIS C; HUMAN; MYALGIA; NEUTROPENIA; PATIENT CARE; PATIENT MONITORING; REVIEW; SUPERINFECTION; TABLET FORMULATION; THYROIDITIS; VIRUS REPLICATION; VIRUS TRANSMISSION; WEIGHT REDUCTION;

CHILD; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS;

EID: 29244449821     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2005.10.005     Document Type: Review

References (68)

1. H.Y. Hsu, M.H. Chang, and S.H. Liaw Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan Hepatology 30 1999 1312 1317
2. American Academy of Pediatrics Hepatitis B L. Pickering 2000 red book: report of the Committee on Infectious Diseases 2000 American Academy of Pediatrics Elk Grove Village (IL) 289 301
3. A.S.F. Lok, and C.L. Lai A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children Hepatology 8 1988 1130 1133
4. H. Hsu, M. Chang, and D. Chen Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan J Med Virol 18 1986 301 307
5. F. Bortolotti, P. Cadrobbi, and C. Crivellaro Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood Gastroenterology 99 1990 805 810
6. F. Bortolotti, P. Jara, and C. Crivellaro Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period J Hepatol 29 1998 184 190
7. A. Godra, M.M. Jonas, and A.R. Perez-Atayde Histopathology of the liver in children with chronic hepatitis B Mod Pathol 18 2005 346A
8. M.H. Chang, C.J. Chen, and M.S. Lai Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1997 1906 1907
9. J.J. Young, L. Ries, and E. Silverberg Cancer incidence, survival, and mortality for children younger than age 15 years Cancer 58 2 Suppl 1986 598 602
10. A. Broderick, and M.M. Jonas Management of hepatitis B in children Clin Liver Dis 8 2004 387 401
11. M. Ruíz-Moreno, M.J. Rua, and J. Molina Prospective, randomized trial of interferon-alpha in children with chronic hepatitis B Hepatology 13 1991 1035 1039
12. C. Barbera, F. Bortolotti, and C. Crivellaro Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B Hepatology 20 1994 287 290
13. M.R. Narkewicz, D. Smith, and A. Silverman Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment J Pediatr 127 1995 815 818
14. E.M. Sokal, H.S. Conjeevaram, and E.A. Roberts Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial Gastroenterology 114 1998 988 995
15. G.E. Kobak, T. MacKenzie, and R.J. Sokol Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger J Pediatr 145 2004 340 345
16. R. Giacchino, J. Main, and A. Timitilli Dual-centre, double-blind, randomised trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B Liver 15 1995 143 148
17. F. Gurakan, N. Kocak, and H. Ozen Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection Pediatr Infect Dis J 19 2000 52 56
18. D. Torre, and R. Tambini Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis Clin Infect Dis 23 1996 131 137
19. L. Comanor, J. Minor, and H. Conjeevaram Statistical models for predicting response to interferon-alfa and spontaneous seroconversion in children with chronic hepatitis B J Viral Hepat 7 2000 144 152
20. M.M. Jonas, D.A. Kelly, and J. Mizerski Clinical trial of lamivudine in children with chronic hepatitis B N Engl J Med 346 2002 1706 1713
21. X. Hom, N. Little, and S. Gardner Predictors of virologic response to lamivudine treatment in children with chronic hepatitis B infection Pediatr Infect Dis 23 5 2004 441 445
22. R. Iorio, P. Pensati, and S. Botta Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis Pediatr Infect Dis J 16 1997 984 990
23. L. Comanor, J. Minor, and H.S. Conjeevaram Impact of chronic hepatitis B and interferon-alfa therapy on growth of children J Viral Hepat 8 2001 139 147
24. E. Sokal, J. Mizerski, and M. Woynarowski An extended, stratified, follow-on study in children with chronic hepatitis B (CHB) who have completed previous lamivudine studies [abstract] Hepatology 38 Suppl. 1 2003 710A
25. Y.-F. Liaw, N.W.Y. Leung, and T.-T. Chang Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 2000 2000 172 180
26. N.W.Y. Leung, C.-L. Lai, and T.-T. Chang Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy Hepatology 33 2001 1527 1532
27. B. Dikici, M. Bosnak, and I.H. Kara Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection Pediatr Infect Dis J 20 2001 988 992
28. M.A. Selimoglu, S. Aydogdu, and F. Unal Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children Pediatr Int 44 2002 404 408
29. V. Di Marco, R. Giacchino, and A. Timitilli Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study J Viral Hepat 3 1996 123 128
30. G. Dalekos, E. Galanakis, and E. Zervou Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience Hepatogastroenterology 47 2000 1072 1076
31. M.B. Ristig, J. Crippin, and J.A. Aberg Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed J Infect Dis 186 2002 1844 1847
32. Y. Benhamou, R. Tubiana, and V. Thibault Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus N Engl J Med 348 2003 177 178
33. G.J. Dore, D.A. Cooper, and A.L. Pozniak Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and experienced patients coinfected with HIV-1 and hepatitis B virus J Infect Dis 189 2004 1185 1192
34. P. Marcellin, T.-T. Chang, and S.G. Lim Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808 816
35. S.J. Hadziyannis, N.C. Tassopoulos, and E.J. Heathcote Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B N Engl J Med 348 2003 800 807
36. P. Marcellin, T.T. Chang, and S. Lim Long term efficacy and safety of adefovir dipivoxil 10 mg in HBeAg + chronic hepatitis B patients: increasing serologic, virologic, and biochemical response over time Hepatology 40 Suppl 1 2004 655A
37. H.L.A. Janssen, M. van Zonneveld, and H. Senturk Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 365 2005 123 129
38. P. Marcellin, G.K. Lau, and F. Bonino Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 351 2004 1206 1217
39. N.V. Naoumov, and J. Hou The emerging role of hepatitis B virus genotypes Current Hepatitis Reports 3 2004 145 151
40. Y.H. Ni, M.H. Chang, and K.J. Wang Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma Gastroenterology 127 2004 1733 1738
41. C.T. Wai, C.J. Chu, and M. Hussainn HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C Hepatology 36 2002 1425 1430
42. J.H. Kao, N.H. Wu, and P.J. Chen Hepatitis B genotypes and the response to interferon J Hepatol 33 2000 998 1002
43. H.L. Chan, M.L. Wong, and A.Y. Hui Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment World J Gastroenterol 9 2003 2695 2697
44. C. Westland, W. Delaney IV, and H. Yang Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil Gastroenterology 125 2003 107 116
45. J. Hou, R. Schilling, and H.L.S. Janssen Molecular characteristics of hepatitis B virus genotype A confer a higher response rate to interferon treatment J Hepatol 34 Suppl 1 2001 15
46. Committee on Infectious Diseases American Academy of Pediatrics Hepatitis C virus infection Pediatrics 101 1998 481 485
47. F. Bortolotti, M. Resti, and R. Giacchino Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children J Pediatr 133 1998 378 381
48. L.T.F. Yeung, S.M. King, and E.A. Roberts Mother-to-infant transmission of hepatitis C virus Hepatology 34 2001 223 229
49. M. Resti, P. Jara, and L. Hierro Clinical features and progression of perinatally acquired hepatitis C virus infection J Med Virol 70 2003 373 377
50. P. Jara, M. Resti, and L. Hierro Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children Clin Infect Dis 36 2003 275 280
51. M. Vogt, T. Lang, and G. Frosner Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening N Engl J Med 341 1999 866 870
52. K. Badizadegan, M.M. Jonas, and M.J. Ott Histopathology of the liver in children with chronic hepatitis C viral infection Hepatology 28 1998 1416 1423
53. M. Kage, T. Fujisawa, and K. Shiraki Pathology of chronic hepatitis C in children Hepatology 26 1997 771 775
54. M. Guido, M. Rugge, and P. Jara Chronic hepatitis C in children: the pathological and clinical spectrum Gastroenterology 115 1998 1525 1529
55. R. Gonzalez-Peralta, M. Langham, and P. Mohan Hepatocellular carcinoma in two adolescents with cirrhosis secondary to hepatitis C virus infection J Pediatr Gastroenterol Nutr 37 2003 380
56. K.R. Jacobson, K. Murray, and A. Zellos An analysis of published trials of interferon monotherapy in children with chronic hepatitis C J Pediatr Gastroenterol Nutr 34 2002 52 58
57. R. Gonzalez-Peralta, B.A. Haber, and M.M. Jonas Interferon-alfa2b in combination with ribavirin for the treatment of chronic hepatitis C in children [abstract] Hepatology 36 part 2 2002 311A
58. M.W. Fried, M.L. Shiffman, and K.J. Reddy Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
59. S. Wirth, H. Pieper-Boustani, and T. Lang Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C Hepatology 41 2005 1013 1018
60. H. Lackner, A. Moser, and J. Deutsch Interferon-α and ribavirin in treating children and young adults with chronic hepatitis C after malignancy Pediatrics 106 4 2000 E53
61. B. Christensson, T. Wiebe, and A. Akesson Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission Clin Infect Dis 30 2000 585 586
62. S. Wirth, T. Lang, and S. Gehring Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C Hepatology 36 2002 1280 1284
63. M.P. Manns, J.G. McHutchison, and S.C. Gordon Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 22 2001 958 965
64. K.B. Schwarz, P. Mohan, and M.R. Narkewicz The safety, efficacy and pharmacokinetics of peginterferon alfa-2a (40kD) in children with chronic hepatitis C [abstract] Gastroenterology 124 4 Suppl 1 2003 A700
65. J.H. Hoofnagle This month from the NIH: peds-C Hepatology 41 2004 421
66. P. Marcellin, Y. Horsmans, and F. Nevens A phase II, placebo-controlled study of merimepodib (VX-497), in combination with pegylated interferon alfa and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon alfa and ribavirin J Hepatol 40 2004 145
67. M. Reiser, H. Hinrichsen, and Y. Benhamou Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C Hepatology 41 2005 832 835
68. H. Hinrichsen, Y. Benahmou, and H. Wedemeyer Two days of oral treatment with BILN-2061, a HCV serine protease inhibitor, in patients with genotype 1 hepatitis C Gastroenterology 127 2004 1347 1355